These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 23738642

  • 1. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
    Ono S, Tanioka M, Tanizaki H, Fujisawa A, Koga H, Hashimoto T, Kamiya K, Aoyama Y, Iwatsuki K, Miyachi Y.
    Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
    [No Abstract] [Full Text] [Related]

  • 2. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
    Nagamoto E, Fujisawa A, Jinnin M, Koga H, Ishii N, Hashimoto T, Yoshino Y.
    J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
    [No Abstract] [Full Text] [Related]

  • 3. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
    Ingen-Housz-Oro S, Hüe S, Grootenboer-Mignot S, André C.
    Ann Dermatol Venereol; 2013 Jul; 140(8-9):563-70. PubMed ID: 24034645
    [No Abstract] [Full Text] [Related]

  • 4. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N, Echigo T, Okochi H, Tamaki K.
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [Abstract] [Full Text] [Related]

  • 5. Anti-desmogleins autoantibodies detected by ELISA and blotting in bullous pemphigoid: what do they mean?
    Julio T, Vernal S, Turatti A, Roselino AM.
    Int J Dermatol; 2018 Jan; 57(1):124-127. PubMed ID: 29152717
    [No Abstract] [Full Text] [Related]

  • 6. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.
    Roussel A, Benichou J, Randriamanantany ZA, Gilbert D, Drenovska K, Houivet E, Tron F, Joly P.
    Arch Dermatol; 2011 Mar; 147(3):293-8. PubMed ID: 21422336
    [Abstract] [Full Text] [Related]

  • 7. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
    Chan LS.
    Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
    [No Abstract] [Full Text] [Related]

  • 8. BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?
    Schmidt T, Sitaru C, Amber K, Hertl M.
    Br J Dermatol; 2014 Aug; 171(2):212-9. PubMed ID: 24601973
    [Abstract] [Full Text] [Related]

  • 9. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
    Huang MX, Li ZS, Luo DQ, Lin Q.
    G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
    Lai FJ, Sheu HM, Lee JY, Cheng CL, Chen W.
    Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An immunogenetic study of bullous pemphigoid with mucosal involvement in two siblings.
    Minagawa A, Arakura F, Koga H, Tokuda Y, Koga H, Hashimoto T, Okuyama R.
    Eur J Dermatol; 2015 Apr; 25(2):186-8. PubMed ID: 25513716
    [No Abstract] [Full Text] [Related]

  • 17. Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients.
    Ingen-Housz-Oro S, Plée J, Belmondo T, Maizières M, Pham BN, Hüe S, Ortonne N, Durlach A, Wolkenstein P, Chosidow O, Bernard P.
    Dermatology; 2015 Apr; 231(1):50-5. PubMed ID: 25871736
    [Abstract] [Full Text] [Related]

  • 18. Serological studies in bullous pemphigoid: a literature review of antibody titers at presentation and in clinical remission.
    Leuci S, Gürcan HM, Ahmed AR.
    Acta Derm Venereol; 2010 Mar; 90(2):115-21. PubMed ID: 20169293
    [Abstract] [Full Text] [Related]

  • 19. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
    Ghohestani RF, Claudy A.
    Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
    [No Abstract] [Full Text] [Related]

  • 20. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
    Hara H, Makino T, Matsui K, Takegami Y, Koga H, Fukuda S, Ishii N, Hashimoto T, Shimizu T.
    Eur J Dermatol; 2014 Aug; 24(4):488-9. PubMed ID: 25178966
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.